or Try an Advanced Search...

    Technical Analysis for CYTH - Cyclo Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.70 -1.24% -0.01
    CYTH closed up 4.08 percent on Wednesday, November 20, 2024, on 26 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CYTH trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.24%
    NR7 Range Contraction -1.24%
    Narrow Range Bar Range Contraction -1.24%
    Inside Day Range Contraction -1.24%
    Gapped Up Strength -1.24%
    20 DMA Resistance Bearish 2.79%
    50 DMA Resistance Bearish 2.79%
    180 Bearish Setup Bearish Swing Setup 2.79%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.79%
    Gapped Down Weakness 2.79%
    Older End-of-Day Signals for CYTH ...

       Recent Intraday Alerts

    Alert Time
    Gap Down Partially Closed about 1 hour ago
    60 Minute Opening Range Breakout about 1 hour ago
    Gapped Down (Partial) about 4 hours ago
    Down 3% about 4 hours ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CYTH Chart by TradingView
    Basic chart:

    Profile

    Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. The company is planning an early phase clinical trial using Trappsol Cyclo intravenously in Alzheimer’s Disease based on encouraging data from an Expanded Access program for late-onset Alzheimer’s Disease. Additional indications for the active ingredient in Trappsol Cyclo are in development.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Medicine Rare Diseases Alzheimer's Disease Lipid Storage Disorders

    Is CYTH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 22 Cyclo Therapeutics falls after merger agreement with Rafael Holdings
    Aug 22 Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement
    Aug 17 Cyclo Therapeutics Second Quarter 2024 Earnings: Misses Expectations
    Jul 29 Cyclo Therapeutics Announces Notice of Decision to Grant European Patent Application for Treatment of Alzheimer’s Disease from European Patent Office
    Jun 25 Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024
    Jun 14 Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
    May 30 Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
    See more CYTH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.115
    52 Week Low 0.5946
    Average Volume 30,419
    200-Day Moving Average 1.16
    50-Day Moving Average 0.72
    20-Day Moving Average 0.72
    10-Day Moving Average 0.70
    Average True Range 0.05
    RSI (14) 48.19
    ADX 16.11
    +DI 10.31
    -DI 16.42
    Chandelier Exit (Long, 3 ATRs) 0.66
    Chandelier Exit (Short, 3 ATRs) 0.77
    Upper Bollinger Bands 0.78
    Lower Bollinger Band 0.66
    Percent B (%b) 0.41
    BandWidth 17.76
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0016
    Fundamentals Value
    Market Cap 20.27 Million
    Num Shares 28.6 Million
    EPS -1.59
    Price-to-Earnings (P/E) Ratio -0.45
    Price-to-Sales 51.42
    Price-to-Book 1.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.74
    Resistance 3 (R3) 0.74 0.72 0.73
    Resistance 2 (R2) 0.72 0.72 0.72 0.73
    Resistance 1 (R1) 0.72 0.71 0.72 0.72 0.73
    Pivot Point 0.70 0.70 0.70 0.70 0.70
    Support 1 (S1) 0.70 0.70 0.70 0.70 0.69
    Support 2 (S2) 0.68 0.69 0.68 0.69
    Support 3 (S3) 0.68 0.68 0.68
    Support 4 (S4) 0.68